The aim of the current research has been to validate an original radioiodin
ated diprenorphine (DPN) derivative suitable for imaging studies of opioid
receptors. [I-125]7 alpha-O-iodoallyl diprenorphine (7 alpha-O-IA-DPN) was
prepared by radioiododestannylation and in vitro and in vivo opioid recepto
r binding assays were performed with CDF1 mouse brains.
In vitro binding studies showed high affinity (K-i = 0.4 +/- 0.2 nM) for mo
use brain membranes. In vivo studies showed 63% specific binding. Ex vivo a
utoradiography of brain sections confirmed high uptake and retention of [I-
125]7 alpha-O-IA-DPN in regions rich in opioid receptors. This new radioiod
inated DPN analogue appears to be a potential radioprobe for in vivo visual
ization of human cerebral opioid receptors with single photon emission comp
uted tomography (SPECT). (C) 1999 Harcourt Publishers Ltd.